Literature DB >> 16730064

Ficolin-2 recognizes DNA and participates in the clearance of dying host cells.

Maria Lund Jensen1, Christian Honoré, Tina Hummelshøj, Bjarke Endel Hansen, Hans Ole Madsen, Peter Garred.   

Abstract

Ficolin-2 is a serum opsonin, which has been shown to be a pattern recognition molecule in the lectin complement activation pathway. Because innate immune mechanisms are involved in maintaining tissue homeostasis we hypothesized that Ficolin-2 also participate in the clearance of dying host cells. We found that Ficolin-2 binds to late apoptotic cells, as well as to apoptotic bodies and necrotic cells, but not to early apoptotic cells. We demonstrated that Ficolin-2 binds DNA in a calcium dependent manner and that DNA inhibits the binding to late apoptotic and necrotic cells, suggesting that DNA on permeable dying cells is a plausible ligand. Reconstituting serum deficient of Ficolin-2, C1q and mannose-binding lectin with Ficolin-2 augmented deposition of complement C4 on necrotic cells. Opsonization leads to an enhanced attachment/uptake of necrotic cells by macrophages. In conclusion dying host cells expose ligands with the capacity of binding Ficolin-2, which in turn leads to increased attachment and engulfment. Binding of Ficolin-2 to DNA points at nucleic acid exposed by permeable late apoptotic and necrotic cells as one of the ligands for Ficolin-2. Ficolin-2 may therefore be a scavenger molecule participating in the removal of host cells and maintenance of tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730064     DOI: 10.1016/j.molimm.2006.04.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  38 in total

1.  Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium.

Authors:  Shuning Huang; Howard H Chen; Hushan Yuan; Guangping Dai; Daniel T Schuhle; Choukri Mekkaoui; Soeun Ngoy; Ronglih Liao; Peter Caravan; Lee Josephson; David E Sosnovik
Journal:  Circ Cardiovasc Imaging       Date:  2011-08-11       Impact factor: 7.792

2.  Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.

Authors:  Jie Tian; Zhili Xu; Jeffrey S Smith; Sean E Hofherr; Michael A Barry; Andrew P Byrnes
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

3.  Blood collection tubes influence serum ficolin-1 and ficolin-2 levels.

Authors:  Allison M Brady; Brady L Spencer; Ann R Falsey; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

4.  Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus.

Authors:  A Troldborg; S Thiel; L Jensen; S Hansen; M J Laska; B Deleuran; J C Jensenius; K Stengaard-Pedersen
Journal:  Clin Exp Immunol       Date:  2015-08-31       Impact factor: 4.330

Review 5.  Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing.

Authors:  Lorena Zuliani-Alvarez; Kim S Midwood
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-05-01       Impact factor: 4.730

6.  Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis.

Authors:  M-L Metzger; I Michelfelder; S Goldacker; K Melkaoui; J Litzman; D Guzman; B Grimbacher; U Salzer
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

7.  Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus.

Authors:  Nima Tanha; Katrine Pilely; Mikkel Faurschou; Peter Garred; Søren Jacobsen
Journal:  Clin Rheumatol       Date:  2016-12-15       Impact factor: 2.980

8.  Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease.

Authors:  I J Messias-Reason; M D Schafranski; P G Kremsner; J F J Kun
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

9.  Commercially available complement component-depleted sera are unexpectedly codepleted of ficolin-2.

Authors:  Allison M Brady; K Aaron Geno; Alex G Dalecki; Xiaogang Cheng; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2014-07-16

10.  Recognition of acetylated oligosaccharides by human L-ficolin.

Authors:  Anders Krarup; Daniel A Mitchell; Robert B Sim
Journal:  Immunol Lett       Date:  2008-04-28       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.